Carregant...
A rare cutaneous adverse effect secondary to cabozantinib therapy
Cabozantinib is a tyrosine kinase inhibitor which is increasingly being used for the treatment of metastatic renal cell cancer. Skin toxicity such as palmar-plantar erythrodysesthesia is not uncommon with such agents. However, bullous skin reactions are not common and we report the case of a patient...
Guardat en:
| Publicat a: | Oxf Med Case Reports |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6252307/ https://ncbi.nlm.nih.gov/pubmed/30487990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omy105 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|